Johnson & Johnson vaccine: Why Americans shouldn’t turn their noses up at J&J’s coronavirus vaccine
3 years, 9 months ago

Johnson & Johnson vaccine: Why Americans shouldn’t turn their noses up at J&J’s coronavirus vaccine

CNN  

CNN — Americans are taking another look at Johnson & Johnson’s Covid-19 vaccine and its data after the vaccine received emergency use authorization by the US Food and Drug Administration on Saturday. “My big concern here is that the Johnson & Johnson is being labeled as the inferior vaccine,” said Dr. Leana Wen, a CNN medical analyst and former Baltimore public health commissioner, “when that’s not a fair assessment to make.” It’s very effective against severe disease On Wednesday, the FDA released an analysis of vaccine clinical trial data submitted by Johnson & Johnson, saying the vaccine met the FDA’s requirements for emergency use authorization. And all three of these vaccines appear terrific for that goal.” You can’t make head-to-head comparisons After Johnson & Johnson released its data last month, Dr. Anthony Fauci told CNN the vaccine had “very good efficacy against severe disease,” and that the results would have looked even better if it weren’t for the fact it had to compete with the vaccines from Pfizer-BioNTech and Moderna. Offering protection against the variant could give the Johnson & Johnson vaccine a “slight edge,” Wen said, since neither Pfizer’s nor Moderna’s vaccine was tested in that environment. “If people are offered the Johnson & Johnson vaccine, they shouldn’t say, ‘I don’t want it,’” Goepfert said.

Disease Vaccines Cnn Johnson Covid Fda Vaccine Moderna Severe Effective Prevent Wen Pfizer Severe Disease Efficacy One Group Johnson Vaccine Goepfert  disease  coronavirus  wen  johnson  noses  americans  severe  efficacy  prevent  shouldnt  jjs  vaccines  thats  effective  turn  vaccine

History of this topic

New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration
3 months, 3 weeks ago

New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration

ABC  

Australia's national drug regulator is evaluating the safety and efficacy of two new COVID-19 vaccines designed to provide better protection against new variants of the virus. While there is no longer much circulation of the original JN.1 variant in Australia, Professor Esterman said the new vaccines — targeting JN.1 — would likely still prove highly effective. While TGA approval isn't …

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines
6 months, 2 weeks ago

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines

Associated Press  

WASHINGTON — Government advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall -- targeting a version of the ever-evolving coronavirus called JN.1. But just a few months later, numerous offshoots of JN.1 already are on the rise, prompting Moderna and Pfizer to also test a slightly different vaccine formula targeting …

Newest COVID shots are 54% effective in preventing symptoms, CDC finds
10 months, 3 weeks ago

Newest COVID shots are 54% effective in preventing symptoms, CDC finds

Associated Press  

NEW YORK — The latest versions of COVID-19 vaccines were 54% effective at preventing symptomatic infection in adults, according to the first U.S. study to assess how well the shots work. The 54% finding is similar to what’s been reported in other countries, and it’s also about what was reported for an earlier vaccine version, said the Ruth Link-Gelles of …

Johnson & Johnson wants to shutter Leiden vaccine lab; cut jobs
1 year, 4 months ago

Johnson & Johnson wants to shutter Leiden vaccine lab; cut jobs

NL Times  

The Leiden pharmaceutical company Janssen intends to largely close its vaccine department because the American parent company Johnson & Johnson wants to focus more on other, new treatment methods. In 2021, then coronavirus minister Hugo de Jonge promoted the vaccine with the slogan “Dance with Janssen.” Many young people responded. But, in the following weeks, that led to many coronavirus …

As COVID-19 spikes in California, booster shots could make all the difference
2 years ago

As COVID-19 spikes in California, booster shots could make all the difference

LA Times  

With coronavirus cases and hospitalizations rising in Los Angeles County, officials are voicing new confidence in the effectiveness of the updated COVID-19 booster shot. New data has found that the updated COVID-19 vaccines offer “significant additional protection” against symptomatic infection in people who were previously vaccinated or boosted with the older formula. “We have seen very low uptake of the …

J&J COVID vaccine factory forced to trash even more doses
2 years, 4 months ago

J&J COVID vaccine factory forced to trash even more doses

Associated Press  

WASHINGTON — About 135 million more doses of Johnson & Johnson’s COVID-19 vaccine from a troubled Baltimore factory will have to be destroyed due to quality problems, Congressional panel leaders said Thursday. The announcement follows a report in May that detailed how more than 400 million vaccine doses made at an Emergent BioSolutions plant had to be trashed. Johnson & …

FDA advisers back Novavax COVID-19 shots as fourth US option
2 years, 6 months ago

FDA advisers back Novavax COVID-19 shots as fourth US option

Firstpost  

The FDA advisory panel voted that the benefits of two primary Novavax doses outweigh its risks — but they had a lot of questions about the shots’ role at this point in the pandemic. Next, the FDA must decide whether to authorize the protein vaccine made by latecomer Novavax as the nation’s fourth coronavirus shot for adults. FDA’s vaccine chief …

Advisers to the FDA back Novavax COVID vaccine
2 years, 6 months ago

Advisers to the FDA back Novavax COVID vaccine

NPR  

Advisers to the FDA back Novavax COVID vaccine Enlarge this image toggle caption Karen Ducey/Getty Images Karen Ducey/Getty Images In a 21-0 vote with one abstention, advisers to the Food and Drug Administration recommended that the agency authorize Novavax's two-dose vaccine against COVID-19. In comments to the committee before its vote, Dr. Peter Marks, the FDA's top vaccine official said, …

WHO Says Second Booster Jab Beneficial For Vulnerable Population
2 years, 7 months ago

WHO Says Second Booster Jab Beneficial For Vulnerable Population

News 18  

An expert group convened by the World Health Organization says there may be some benefit in giving a second booster dose of coronavirus vaccine to the most vulnerable people amid the continuing global spread of omicron and its subvariants. The WHO said its expert group had assessed the limited data from seven studies for second booster doses of messenger RNA …

Africa's COVID vaccine production line in jeopardy
2 years, 7 months ago

Africa's COVID vaccine production line in jeopardy

The Hindu  

Trisha shakes her head when asked if she's vaccinated. 'A massive setback for Africa's plans' In the absence of orders or commitments, Aspen is considering the repurposing of two COVID-19 production lines for the manufacture of other products. "The continent would lose its only existing COVID vaccine manufacturing capacity," Nicolaou says. Africa's major public health body, the Africa Centers for …

New plant-based Covid vaccine 70% effective against variants: Study
2 years, 7 months ago

New plant-based Covid vaccine 70% effective against variants: Study

India Today  

A new plant-based Covid-19 vaccine is nearly 70 per cent effective against symptomatic disease caused by five variants of the coronavirus, according to results of the human clinical trial of the preventive. The study, published on Thursday in the New England Journal of Medicine, shows that the vaccine efficacy was 69.5 per cent against any symptomatic Covid-19 caused by five …

J&J Covid-19 vaccine ‘limited’ to some people after clot concerns: Report
2 years, 7 months ago

J&J Covid-19 vaccine ‘limited’ to some people after clot concerns: Report

Hindustan Times  

Johnson & Johnson’s Covid-19 vaccine was limited to use only in adults for whom other shots aren’t appropriate after an investigation of rare and potentially deadly clotting disorder that occurs in some recipients. J&J’s single-shot vaccine has been noted for its convenience compared to two-shot vaccines, especially in remote areas and in populations like the homeless who may be difficult …

FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk
2 years, 7 months ago

FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk

LA Times  

Vials of the Johnson & Johnson COVID-19 vaccine are seen at a pharmacy in 2021. U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. FDA officials said in a statement that they decided to restrict J&J’s vaccine after taking another look at data on …

US regulators approve 2nd COVID booster for those aged 50 and up
2 years, 8 months ago

US regulators approve 2nd COVID booster for those aged 50 and up

Al Jazeera  

US has seen a small uptick in new COVID-19 cases during the past week, raising concern that infections could surge again. Regulators in the United States have authorised another COVID-19 booster shot for people aged 50 and older, amid concerns that coronavirus infections may begin rising again due to waning immunity to Omicron variants. “Based on an analysis of emerging …

J&J vaccine recipients were FIVE TIMES as likely to be hospitalized with Covid as Pfizer recipients
2 years, 9 months ago

J&J vaccine recipients were FIVE TIMES as likely to be hospitalized with Covid as Pfizer recipients

Daily Mail  

The Johnson & Johnson COVID-19 vaccine was not nearly as effective as its peers at preventing hospitalization from the virus, a new study of elderly patients finds. A French research team found that 28 days after administration of the single-dose J&J shot, and the second dose of the Pfizer-BioNTech vaccine, the J&J recipients were 5.2 times more likely to be …

Over-50s set to be offered Covid booster vaccines this autumn
2 years, 10 months ago

Over-50s set to be offered Covid booster vaccines this autumn

The Telegraph  

Millions of over-50s could be offered Covid boosters this autumn, as Boris Johnson hailed Britain's vaccine rollout as key to "restoring our liberties in full". Fourth jabs will start being offered to those aged 75 and over from next month, with a further rollout of vaccines expected later this year, when the programme may be much more widely extended. Announcing …

A different COVID-19 vaccine debate: Do we need new shots?
2 years, 10 months ago

A different COVID-19 vaccine debate: Do we need new shots?

LA Times  

A technician inspects filled vials of the Pfizer-BioNTech COVID-19 vaccine at the company’s facility in Puurs, Belgium. to believe that any kind of vaccination is going to protect people from infection, from mild symptomatic disease, forever.” If the goal is preventing serious illness, “we may not need to be doing as much fine-tuning of the vaccines every time a new …

Why are so many vaccinated people getting COVID-19 lately?
2 years, 11 months ago

Why are so many vaccinated people getting COVID-19 lately?

Associated Press  

Why are so many vaccinated people getting COVID-19 lately? Omicron is more likely to infect people, even if it doesn’t make them very sick, and its surge coincided with the holiday travel season in many places. People might mistakenly think the COVID-19 vaccines will completely block infection, but the shots are mainly designed to prevent severe illness, says Louis Mansky, …

New COVID studies show promise for the Johnson & Johnson vaccine booster
2 years, 11 months ago

New COVID studies show promise for the Johnson & Johnson vaccine booster

NPR  

New COVID studies show promise for the Johnson & Johnson vaccine booster Enlarge this image toggle caption Rajesh Jantilal/AFP via Getty Images Rajesh Jantilal/AFP via Getty Images Two new studies of a Johnson & Johnson COVID-19 vaccine booster showed promise against the omicron variant at a time when public health officials are urgently recommending booster shots against the fast-spreading variant. …

US health experts recommend Pfizer, Moderna COVID-19 shots over J&J vaccine
3 years ago

US health experts recommend Pfizer, Moderna COVID-19 shots over J&J vaccine

Firstpost  

The panel cited the risk of rare but sometimes fatal cases of blood clotting as well as a lower level of effectiveness against COVID-19 in the Johnson & Johnson shot Washington: Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, United States health officials …

CDC advisers review blood-clotting risk associated with J&J’s covid-19 vaccine
3 years ago

CDC advisers review blood-clotting risk associated with J&J’s covid-19 vaccine

Live Mint  

U.S. vaccine advisers are scheduled to consider whether to change recommendations on the use of Johnson & Johnson’s Covid-19 vaccine because of the risk of a rare but serious blood-clotting condition. The Advisory Committee on Immunization Practices will hear updates Thursday from Centers for Disease Control and Prevention officials on reports of J&J vaccine recipients experiencing blood clots combined with …

US CDC panel votes to recommend mRNA COVID-19 vaccines over J&J’s
3 years ago

US CDC panel votes to recommend mRNA COVID-19 vaccines over J&J’s

Al Jazeera  

The US had briefly paused use of the COVID jab in April, before finding benefit outweighs very rare, but deadly, risks. A panel of outside advisers to the US Centers for Disease Control and Prevention has voted to recommend Americans choose to receive one of the other two authorised COVID-19 vaccines over Johnson & Johnson’s shot, due to rare but …

The big vaccine pivot: Merck falters on Covid-19 shots, then makes one for rival
3 years ago

The big vaccine pivot: Merck falters on Covid-19 shots, then makes one for rival

Live Mint  

Weeks after Merck & Co. scrapped development of its Covid-19 vaccines in January, one of its senior manufacturing officials began phoning his deputies, telling them their work on a pandemic shot wasn’t actually over. J&J’s unusual collaboration with a rival, and Merck’s speedy manufacturing run-up, reflect one of the biggest challenges of the pandemic: making enough Covid-19 vaccines to meet …

COVID-19 boosters on backburner for most pro sports leagues
3 years ago

COVID-19 boosters on backburner for most pro sports leagues

Associated Press  

The push to get vaccine booster shots is not an immediate priority in most of the top sports leagues in North America even with delta and omicron variants spreading. “We’re not at that point yet,” NHLPA executive director Don Fehr said when asked about making boosters count as being fully vaccinated for the league’s approximately 700 players. “We’re doing whatever …

J&J Covid vaccine booster raised immune response after Pfizer vaccine, study finds
3 years ago

J&J Covid vaccine booster raised immune response after Pfizer vaccine, study finds

CNN  

CNN — Using the Johnson & Johnson vaccine as a booster for people initially immunized with the Pfizer/BioNTech vaccine produces a strong immune response and may do more to elicit protection against severe disease, researchers reported Sunday. Their small study of 65 volunteers who all initially got two doses of Pfizer/BioNTech’s vaccine showed that using the J&J Janssen vaccine as …

Protection offered by booster shot beats ‘natural immunity,’ study suggests
3 years ago

Protection offered by booster shot beats ‘natural immunity,’ study suggests

LA Times  

Michael Stremfel prepares a COVID-19 booster shot at Flintridge Pharmacy in La Cañada Flintridge. A new study finds that people who got a booster shot generated much higher levels of neutralizing antibodies than people who had a coronavirus infection. A small study that’s among the first to track people’s protective antibodies over time found that those who were immunized against …

European Union Considers Booster Doses of J&J's Covid-19 Vaccine
3 years, 1 month ago

European Union Considers Booster Doses of J&J's Covid-19 Vaccine

News 18  

The European Medicines Agency says it is evaluating whether to authorize booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine. In a statement Monday, the EU drug regulator said it was considering an application from J&J to recommend booster doses of the J&J vaccine for adults 18 and over, at least two months after they were first immunized. The U.S. …

US expands Covid-19 booster eligibility to all adults
3 years, 1 month ago

US expands Covid-19 booster eligibility to all adults

India Today  

US regulators expanded eligibility for booster shots of Covid-19 vaccines to all adults on Friday, allowing millions more Americans to get additional protection against the virus amid a recent rise in infections. The director of the Centers for Disease Control and Prevention, Rochelle Walensky, signed off on the expanded eligibility on Friday evening after the US Food and Drug Administration …

Covid-19: J&J's Hyderabad-made Jabs Get CDL Nod, Over 1 Cr Doses Ready for Export
3 years, 1 month ago

Covid-19: J&J's Hyderabad-made Jabs Get CDL Nod, Over 1 Cr Doses Ready for Export

News 18  

American pharma giant Johnson & Johnson’s Covid-19 vaccine shots, manufactured in India by Hyderabad-based Biological E, are ready for export, News18.com learnt. “Once the Drug Controller General of India approves the report sent by CDL and the request filed by the company, the batches can be exported.” The move is in line with Prime Minister Narendra Modi’s announcement at the …

Johnson & Johnson's COVID-19 vaccine is 74% effective at preventing infection, study finds
3 years, 1 month ago

Johnson & Johnson's COVID-19 vaccine is 74% effective at preventing infection, study finds

Daily Mail  

Johnson & Johnson's COVID-19 vaccine is more than 70 percent effective at preventing infection, a new study finds. However, despite the effectiveness, the team still recommend people to get the Pfizer or Moderna vaccines if possible Researchers found that 0.7% of people vaccinated with the J&J vaccine contracted Covid during the study period, compared to 2.5% of unvaccinated people After …

New Jersey hospital becomes first to mandate BOOSTER shots for workers with J&J single dose vaccine
3 years, 1 month ago

New Jersey hospital becomes first to mandate BOOSTER shots for workers with J&J single dose vaccine

Daily Mail  

A New Jersey hospital has become the first to mandate booster shots for workers who have had the single-dose Johnson & Johnson vaccine. Elnahal made the announcement in a statement on October 27 Workers affected by the mandate could get the booster shot from J&J, or mix-and-match with Pfizer's, or half a dose of Moderna's More than 66percent of the …

People who got Covid-19 vaccines were less likely to die from any cause compared to unvaccinated people, study finds
3 years, 2 months ago

People who got Covid-19 vaccines were less likely to die from any cause compared to unvaccinated people, study finds

CNN  

CNN — People who got Covid-19 vaccines were not only less likely to die from the virus, but they were less likely to die from any cause over the following months, researchers reported Friday. That’s in addition to the mounting evidence from other studies showing that the COVID-19 vaccines are effective against COVID-19 infection, serious illness, and death.” The team …

Explainer: Is it time to get a COVID-19 booster? Which one?
3 years, 2 months ago

Explainer: Is it time to get a COVID-19 booster? Which one?

LA Times  

Millions more Americans just became eligible for COVID-19 booster shots, but figuring out who should get them and when can be confusing. U.S. health authorities want to shore up protection in at-risk people who were vaccinated months ago, though they emphasize that the priority remains getting the unvaccinated their first shots. If you got Pfizer or Moderna shots first, you’re …

US marks 200M COVID-19 shots shared with world
3 years, 2 months ago

US marks 200M COVID-19 shots shared with world

Associated Press  

WASHINGTON — The U.S. on Thursday donated its 200 millionth COVID-19 shot to help vaccinate the rest of the world, the White House announced. The Biden administration aims to lead a global vaccination campaign even as it rolls out boosters for domestic use, which critics say diverts doses from those who are in greater need around the world. “These 200 …

CDC backs the rollout of COVID vaccine boosters from Moderna and J&J
3 years, 2 months ago

CDC backs the rollout of COVID vaccine boosters from Moderna and J&J

NPR  

CDC backs the rollout of COVID vaccine boosters from Moderna and J&J Enlarge this image toggle caption Michael M. Santiago/Getty Images Michael M. Santiago/Getty Images The Centers for Disease Control and Prevention is backing the roll out of Moderna and Johnson & Johnson COVID-19 vaccine boosters in line with the Food and Drug Administration's authorizations issued Wednesday. A CDC presentation …

CDC endorses booster doses of Moderna and Johnson & Johnson vaccines, says mix and match is fine
3 years, 2 months ago

CDC endorses booster doses of Moderna and Johnson & Johnson vaccines, says mix and match is fine

CNN  

CNN — US Centers for Disease Control and Prevention Director Dr. Rochelle Walensky endorsed recommendations for booster doses for Moderna’s and Johnson & Johnson’s coronavirus vaccines Thursday, allowing millions more Americans to begin getting booster shots. They include people: • 65 years and older • Age 18+ who live in long-term care settings • Age 18+ who have underlying medical …

Pfizer-BioNTech report high efficacy of COVID boosters in study
3 years, 2 months ago

Pfizer-BioNTech report high efficacy of COVID boosters in study

Al Jazeera  

The companies say phase III trial data show booster shot of COVID-19 vaccine was 95.6 percent effective against the disease. American pharmaceutical company Pfizer and its partner BioNTech have said data from a Phase III trial demonstrated high efficacy of a booster dose of their COVID-19 vaccine against the coronavirus, including the Delta variant. They said a trial of 10,000 …

CDC supports expansion of COVID-19 booster rollout and mixing shots
3 years, 2 months ago

CDC supports expansion of COVID-19 booster rollout and mixing shots

LA Times  

Millions more Americans can get a COVID-19 booster and may choose a different company’s vaccine for that next shot, federal health officials said Thursday. Certain people who received Pfizer vaccinations months ago already are eligible for a booster, and now the Centers for Disease Control and Prevention says specific Moderna and Johnson & Johnson recipients qualify, too. Starting six months …

U.S. FDA authorises 'mix and match' COVID-19 vaccine; backs Moderna, J&J boosters
3 years, 2 months ago

U.S. FDA authorises 'mix and match' COVID-19 vaccine; backs Moderna, J&J boosters

The Hindu  

U.S. regulators on October 20 signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially. The Food and Drug Administration’s decisions mark a big step toward expanding the U.S. booster campaign, which began with …

10 crore Indians due for second dose of Covid vaccine but aren't taking it: Dr VK Paul | Exclusive
3 years, 2 months ago

10 crore Indians due for second dose of Covid vaccine but aren't taking it: Dr VK Paul | Exclusive

India Today  

National Covid Task Force chief VK Paul expressed concern over the low numbers in the second dose coverage of the Covid-19 vaccination drive, emphasising that more people need to take it at the earliest. I urge them to shun vaccine hesitancy and prioritise taking the shots now,” Dr VK Paul said in an exclusive interview with India Today. The Niti …

FDA authorizes booster doses of Moderna and Johnson & Johnson vaccines, says mix and match OK
3 years, 2 months ago

FDA authorizes booster doses of Moderna and Johnson & Johnson vaccines, says mix and match OK

CNN  

CNN — The US Food and Drug Administration authorized booster doses of Covid-19 vaccines made by Moderna and Johnson & Johnson Wednesday and also said any of the three authorized vaccines could be used as a booster in a “mix and match” approach. The FDA gave emergency use authorization for a half dose of Moderna’s vaccine as a booster for …

The FDA authorizes Moderna and J&J COVID vaccine boosters
3 years, 2 months ago

The FDA authorizes Moderna and J&J COVID vaccine boosters

NPR  

The FDA authorizes Moderna and J&J COVID vaccine boosters Enlarge this image toggle caption Patrick T. Fallon/AFP via Getty Images Patrick T. Fallon/AFP via Getty Images The Food and Drug Administration authorized booster doses of the COVID-19 vaccines made by Moderna and Johnson & Johnson following unanimous votes by a committee of independent advisers backing the boosters last week. The …

Month On, Johnson & Johnson’s Covid Vaccines Stuck at Kasauli Lab Over Pending Data from Indian Maker
3 years, 2 months ago

Month On, Johnson & Johnson’s Covid Vaccines Stuck at Kasauli Lab Over Pending Data from Indian Maker

News 18  

American pharma giant Johnson & Johnson’s Covid-19 vaccine shots, manufactured in India by Hyderabad-based Biological E, are stuck at the country’s apex vaccine testing laboratory in Himachal Pradesh due to pending data, News18.com has learnt. The batch of around 35 lakh vaccine doses, which arrived at the Central Drugs Laboratory in Kasauli over a month ago, are lying at the …

Why COVID-19 booster shots weren’t tweaked to better match Delta variant
3 years, 2 months ago

Why COVID-19 booster shots weren’t tweaked to better match Delta variant

LA Times  

Vials of the COVID-19 vaccines made by Moderna and Pfizer at a temporary clinic in Exeter, N.H. More COVID-19 booster shots may be on the way — but when it’s your turn, you’ll get an extra dose of the original vaccine formulation, not one updated to better match the extra-contagious Delta variant. The simple answer: The FDA last month OK’d …

FDA panel endorses booster shot for J&J COVID-19 vaccine
3 years, 2 months ago

FDA panel endorses booster shot for J&J COVID-19 vaccine

The Hindu  

U.S. health advisors endorsed a booster of Johnson & Johnson’s COVID-19 vaccine on Friday, citing concern that Americans who got the single-dose shot aren’t as protected as those given two-dose brands. Unable to settle the best timing, the FDA’s advisory panel voted unanimously that the booster should be offered at least two months after people got their earlier shot. “It …

J&J vaccine recipients should get their second dose as soon as it’s available, experts say
3 years, 2 months ago

J&J vaccine recipients should get their second dose as soon as it’s available, experts say

CNN  

CNN — As the greenlight looms for another dose of Johnson & Johnson’s Covid-19 vaccine, experts on Friday urged those who received it to get a booster shot as soon as it’s available because it will provide them with the best protection against the coronavirus. The US Food and Drug Administration advisory committee recommended Friday that all adults who received …

FDA advisers recommend J&J Covid-19 vaccine boosters, talk mix and match boosters
3 years, 2 months ago

FDA advisers recommend J&J Covid-19 vaccine boosters, talk mix and match boosters

CNN  

CNN — Vaccine advisers to the US Food and Drug Administration voted unanimously Friday to recommend a booster dose of Johnson & Johnson’s vaccine at least two months after people get the first dose. The FDA’s Vaccines and Related Biological Products Advisory Committee voted 19-0 to recommend the extra dose for all recipients of the J&J Janssen vaccine, which is …

People who got Janssen vaccine should get mRNA booster, study suggests
3 years, 2 months ago

People who got Janssen vaccine should get mRNA booster, study suggests

NL Times  

Americans vaccinated with the Janssen vaccine have a much stronger immune response to Covid-19 after a booster shot with an mRNA vaccine from Moderna or Pfizer/BioNTech than after a booster with Janssen. All 450 participants had a stronger immune response two weeks after the booster shot, but that effect was the greatest in people who originally received Janssen and then …

US FDA advisers back Moderna’s booster jab for COVID
3 years, 2 months ago

US FDA advisers back Moderna’s booster jab for COVID

Al Jazeera  

With 66 million American adults still unvaccinated, President Biden is pushing for emergency approvals of booster jabs. The FDA’s Vaccines and Related Biological Products Advisory Committee voted unanimously to recommend the booster shot on Thursday and will mull approving an additional dose of the Johnson & Johnson’s vaccine on Friday. Speaking before the panel’s recommendation, President Joe Biden, who is …

Next on FDA's Agenda: Booster Shots of Moderna, J&J Vaccines
3 years, 2 months ago

Next on FDA's Agenda: Booster Shots of Moderna, J&J Vaccines

News 18  

With many Americans who got Pfizer vaccinations already rolling up their sleeves for a booster shot, millions of others who received the Moderna or Johnson & Johnson vaccine wait anxiously to learn when it’s their turn. For example, last month the CDC advisory panel backed Pfizer boosters at the six-month point for older Americans, nursing home residents and people with …

Discover Related